EUVIMEDEUVIMED entdecken
Crossref

A comparative proteomic analysis for non‐invasive early prediction of hypoxic‐ischemic injury in asphyxiated neonates

Sumrati Gurtoo, Gayathree Karthikkeyan, Santosh Kumar Behera, Chinmaya Narayana Kotimoole, Mohd Altaf Najar, Prashant Kumar Modi, Sahana Ks, Sneha M Pinto iD, Arun Ab iD

PROTEOMICS – Clinical Applications · 2024

DOI: 10.1002/prca.202200054 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PROTEOMICS – Clinical Applications, 2024. Verfasst von Sumrati Gurtoo und 8 weiteren Autor:innen. Beteiligte Einrichtung: Center for Systems Biology and Molecular Medicine, Yenepoya Research Centre, Yenepoya (Deemed to be University), Mangalore, Karnataka, India. Hauptthemen laut MEDLINE: Hypoxia-Ischemia, Brain, Stroke. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 71 Literaturangaben. Gefördert von: Yenepoya, Indian Council of Medical Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

Hypoxic Ischemic Encephalopathy (HIE) is one of the principal causes of neonatal mortality and long‐term morbidity worldwide. The neonatal signs of mild cerebral injury are subtle, making an early precise diagnosis difficult. Delayed detection, poor prognosis, and lack of specific biomarkers for the disease are increasing mortality rates. In this study, we intended to identify specific biomarkers using comparative proteomic analysis to predict the severity of perinatal asphyxia so that its outcome can also be prevented. Experimental Design A case‐control study was conducted on 38 neonates, and urine samples were collected within 24 and 72 h of life. A tandem mass spectrometry‐based quantitative proteomics approach, followed by validation via sandwich ELISA, was performed.

Results

The LC‐MS/MS‐based proteomics analysis resulted in the identification of 1201 proteins in urine, with 229, 244, and 426 being differentially expressed in HIE‐1, HIE‐2, and HIE‐3, respectively. Axon guidance, Diseases of programmed cell death, and Detoxification of reactive oxygen species pathways were significantly enriched in mild HIE versus severe HIE. Among the differentially expressed proteins in various stages of HIE, we chose to validate four proteins – APP, AGT, FABP1, and FN1 – via sandwich ELISA. Individual and cumulative ROC curves were plotted. AGT and FABP1 together showed high sensitivity, specificity, and accuracy as potential biomarkers for early diagnosis of HIE.

Conclusion

Establishing putative urinary biomarkers will facilitate clinicians to more accurately screen neonates for brain injury and monitor the disease progression. Prompt treatment of neonates may reduce mortality and neurodevelopmental impairment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hypoxia-Ischemia, BrainStrokeHumansInfant, NewbornFemalePregnancyCase-Control StudiesChromatography, LiquidProteomicsTandem Mass SpectrometryBiomarkers

Stichwörter der Autor:innen

comparative proteomicsdiagnostic marker kithypoxic-ischemic encephalopathymass spectrometryneurodevelopmental disordersnon-invasive biomarkersurinary biomarkers

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Center for Systems Biology and Molecular Medicine, Yenepoya Research Centre, Yenepoya (Deemed to be University), Mangalore, Karnataka, India.
  • Yenepoya Medical College and Hospital, Yenepoya (Deemed to be University), Mangalore, Karnataka, India.
  • Centre of Molecular Inflammation Research (CEMIR), Department of Clinical and Molecular Medicine (IKOM), Norwegian University of Science and Technology, Trondheim, Norway.
  • Yenepoya Research Centre, Yenepoya (Deemed to be University), Mangalore, Karnataka, India.
  • Yenepoya Institute of Arts Science Commerce and Management, Yenepoya (Deemed to be University), Mangalore, Karnataka, India.

ORCID-Profile: Sneha M Pinto, Arun Ab

Förderung

  • Yenepoya
  • Indian Council of Medical Research

Zitieren

APA

Gurtoo, S., Karthikkeyan, G., Behera, S. K., Kotimoole, C. N., Najar, M. A., Modi, P. K., Ks, S., Pinto, S. M., & Ab, A. (2024). A comparative proteomic analysis for non‐invasive early prediction of hypoxic‐ischemic injury in asphyxiated neonates. PROTEOMICS – Clinical Applications. https://doi.org/10.1002/prca.202200054

Vancouver

Gurtoo S, Karthikkeyan G, Behera SK, Kotimoole CN, Najar MA, Modi PK, et al. A comparative proteomic analysis for non‐invasive early prediction of hypoxic‐ischemic injury in asphyxiated neonates. PROTEOMICS – Clinical Applications. 2024. doi:10.1002/prca.202200054

BibTeX
@article{Gurtoo2024,
  author = {Gurtoo, Sumrati and Karthikkeyan, Gayathree and Behera, Santosh Kumar and Kotimoole, Chinmaya Narayana and Najar, Mohd Altaf and Modi, Prashant Kumar and Ks, Sahana and Pinto, Sneha M and Ab, Arun},
  title = {A comparative proteomic analysis for non‐invasive early prediction of hypoxic‐ischemic injury in asphyxiated neonates},
  journal = {PROTEOMICS – Clinical Applications},
  year = {2024},
  doi = {10.1002/prca.202200054}
}
Kostenlos starten →